ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EVG Evgen Pharma Plc

0.775
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.775 0.75 0.80 0.775 0.75 0.75 274,906 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.52 2.12M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.78p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.12 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.52.

Evgen Pharma Share Discussion Threads

Showing 1651 to 1674 of 13025 messages
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older
DateSubjectAuthorDiscuss
16/4/2020
16:41
that site is a bit weird. If Evgen are looking at it, why don't they say so? It would give the share price a boost. I wonder if they tendered for some of the LifeArc grant? They should also talk to the government about the RECOVERY trial, maybe they are but it would be nice to know.
davemac3
16/4/2020
13:47
Personally no, but they have collaboration agreements with Universities of Manchester and also Rochester for development of Sulforaphane based medicines, and both Universities are now heavily involved in Covid-19 research if you check out their websites, and so it stands to reason that they might be working with EVG on potential treatments since Sulforaphane has been highlighted as a possible therapy compound. Gl :-)
moneymunch
16/4/2020
13:36
does anybody know whether Evgen are looking at Sulforaphane as a Covid-19 treatment?
davemac3
16/4/2020
13:16
If this story gets picked up by the weekend press then Monday could be 5th of November all over again !
mesquida
16/4/2020
13:05
managed 17000shares at about 10p after trying at length 9.50 with ii
the patient investor
16/4/2020
13:01
Looking good for news.Gla :-)
moneymunch
16/4/2020
12:54
I've tried to have a little top and yeah and NT so left it as not comfortable with not getting a fixed quote as it'll be dealing for a while and then execute at the day's high two hours later!
tickboo
16/4/2020
12:45
Again the MMs won't let you buy even 1000 shares online! This is not a fair playing field. You get the feeling that they are caught and short and don't want to push it up any further until their book is filled....
nobbygnome
16/4/2020
10:50
Based on the finding that NRF2 activation slows down HSV-1 infection, the researchers tested the effectiveness of two drugs, Bardoxolone methyl and Sulforaphane, that are known to activate the NRF2 pathway, in preventing an HSV-1 infection from taking place.

They found that when cells were treated with these NRF2 agonists, the virus activated fewer of its own genes and consequentially virus production was impaired. This suggested that NRF2 activation restricts viral infection.

These results suggest a potential opportunity to prevent HSV infection in those with low immune systems. However, the researchers don't intend to stop there, with plans already in place to use the same method to investigate another type of herpes virus and coronaviruses.

davemac3
15/4/2020
14:10
Watch SAR: recent tweet https://twitter.com/sareumplc/status/1250384484203102210?s=21Up 35% now
spqstrader
15/4/2020
13:56
Sounds promising Full video ARS, DISH, DEV, EVG, GDR, GLR, N4P, NCYT, ORPH, TILS @ZaksTradersCafehttps://twitter.com/Share_Talk/status/1250337088051933188
tickboo
15/4/2020
13:52
any ideas on cash n debt level. tia
latifs100
15/4/2020
13:38
Dr Meng continued: “Our findings show that timed administration of the antioxidant compound sulforaphane, effectively attenuates the severity of the lung fibrosis in this mouse model.”




................................

moneymunch
15/4/2020
13:31
Dow futures not so good at -416 right now.
Pharma's should stay bright enough whatever:)

bmnsa
15/4/2020
13:28
Well there seems to be a general concensus that sulforaphane based medicines could be beneficial in the fight against Covid, and so any update from EVG along those lines could see this fly. They have collaboration agreements with the University of Rochester and University of Manchester in developing sulforaphane based medicines for the treatment of multiple diseases, and both Universities are now heavily involved in Covid-19 research and development, and so watch this space. Gla ;-)
moneymunch
15/4/2020
13:10
Well let's hope the gap at 15p goes in the coming days.
tickboo
15/4/2020
13:02
15p is where I got in! S will just be relieved if it gets back and then past
toffeeman
15/4/2020
12:45
There's a gap up to around 15p which could well be filled now.....
nobbygnome
15/4/2020
12:45
offering 75k at 10.25p
euclid5
15/4/2020
12:41
Nice move up
trinitygooner
15/4/2020
12:24
Nope still can't get a quote for 1000 shares even now they have moved to 9p.
nobbygnome
15/4/2020
12:19
Still can't even buy 1000 shares on line. FFS the clue is in the name,they are supposed to make a market!
nobbygnome
15/4/2020
12:14
Who knows? But we now have backwardation which just proves it. Peel now bidding 8.8p.
nobbygnome
15/4/2020
12:12
Why are they holding it back?
herb clark
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older

Your Recent History

Delayed Upgrade Clock